How We Help
Neuroendocrine Tumours (NETs) Overview
- Neuroendocrine tumours (NETs) are abnormal growth of cells (neoplasms) that arise from cells of the diffuse neuroendocrine system.
- NETs are considered complex tumours because both tumor growth and hormonal function must be addressed.
- NETs are most common in the lung or gastrointestinal system, but they can also originate in other parts of the body such as the thyroid, thymus, pancreas, adrenals, paraganglia, ovaries and testes.
- NETs are classified as functional (produce hormones that cause symptoms), or non-functional (may or may not produce hormones and do not cause hormonal symptoms).
- The cause of NETs is currently unknown.
Contact Us For Live Support
Support Lines:
416-628-3189
Toll Free: 1-844-628-6788
Latest CNETS Canada News
Dr. Suzanne Richter
It is with profound sadness that we share the news of the passing of Dr. Suzanne Richter, Medical Oncologist on the NET team at London Health Sciences Centre. This is a tremendous loss for the [...]
CCO to provide Ga68 Scan to Ontario patients
CCO to provide Ga-Octreotate to Ontario patients free of charge in Sherbrooke A message from Helena Senta: “At this time, CCO is proceeding with PET scan approval for the PET scans out of province. [...]
Thank you
Thank you to all our donors and volunteers! As we start anew into 2017, CNETS Canada would like to acknowledge and thank all our donors and volunteers for their generosity. We are so grateful for [...]
Campaign Shines Spotlight on Rare Cancer
Media Release Campaign Shines Spotlight on Rare Cancer on November 10th –World NET Cancer Day Toronto, ON – November 10th, 2016 – Today is World NET Cancer Day. To raise awareness about NET cancer, coffee [...]
“LET’S TALK ABOUT NETs”
Media Advisory “LET’S TALK ABOUT NETs” Campaign Shines Spotlight on Rare Cancer Toronto, ON – October 27, 2016 – Between 12,000 to 15,000 Canadians are estimated to have a rare type of cancer called NETs [...]
PRRT Clinical Trial Update – PMH Site
On October 2, 2016, CNETS Canada held a Toronto Patient Education Day entitled PRRT Clinical Trial Update – PMH Site, with presentations by Dr. Rebecca Wong and Dr. Shereen Ezzat. There were 30 attendees, an [...]